Poria for Fluid Balance & Kidney Support

Of everything Poria (Wolfiporia extensa, "Fu Ling") has been used for over two thousand years, its signature role is managing water. Traditional Chinese Medicine describes Poria as an herb that "drains dampness and promotes urination" the historical way of talking about swelling, water retention, and a heavy, waterlogged feeling in the body. Modern laboratory work has found that Poria's lanostane triterpenes do have measurable diuretic activity in animals, and that they may work through a different pathway than the diuretic drugs most people know. But it is essential to be clear-eyed: the strongest evidence is still in rats and test tubes, human trials of Poria on its own are scarce, and Poria is not a substitute for a prescribed diuretic or for the care of a kidney specialist. This page separates the traditional picture from what the science has actually shown.


Table of Contents

  1. What "Draining Dampness" Actually Means
  2. The Parts Used: Fu Ling Pi and the Sclerotium
  3. The Preclinical Diuretic Research
  4. How Poria May Differ from Conventional Diuretics
  5. Poricoic Acids and Kidney-Fibrosis Research
  6. Traditional Formulas for Fluid Retention
  7. What We Still Don't Know
  8. Practical Use, Forms & Cautions
  9. Key Research Papers
  10. Connections
  11. Featured Videos

What "Draining Dampness" Actually Means

In Traditional Chinese Medicine, "dampness" (shi) is a metaphor for the body holding on to fluid it should be moving or clearing — puffy ankles, a bloated abdomen, a heavy sluggish feeling, a swollen tongue with a greasy coating, loose stools. Poria's classical job description is to "drain dampness and promote urination" (li shui shen shi) while doing so gently, without the harshness attributed to stronger draining herbs.

Translated into ordinary physiological language, this maps loosely onto the modern idea of a mild diuretic and fluid-mobilizing agent. It is worth stressing the word loosely: TCM categories were built from centuries of bedside observation, not from measuring urine output in a lab, so the overlap with a pharmacological diuretic is approximate rather than exact. What tradition is confident about is that Poria was reached for whenever a patient seemed to be holding excess water — and that it was considered mild enough to give to children, the elderly, and the debilitated.

That reputation for gentleness matters. Unlike a fast, powerful loop diuretic, Poria was never described as forcing a dramatic fluid loss. It was seen as nudging the body's own water metabolism back toward balance — which is also why traditional practitioners paired it with tonic herbs rather than using it alone.

Back to Table of Contents

The Parts Used: Fu Ling Pi and the Sclerotium

Poria is unusual among "mushrooms" because the part used is not a cap-and-stem fruiting body but the sclerotium — a dense, potato-like underground mass of fungal tissue that forms on the roots of pine trees (Pinus species). Traditional practice recognized several portions of this sclerotium and assigned them slightly different roles, which is directly relevant to fluid balance:

Chemically, the sclerotium is roughly 80–90% polysaccharide by dry weight (mostly the beta-glucan pachyman), plus a smaller but pharmacologically important fraction of lanostane-type triterpenes — pachymic acid, the poricoic acids, dehydrotumulosic acid, dehydrotrametenolic acid, and related molecules. Current thinking attributes most of the diuretic activity to these triterpenes, which are concentrated toward the outer layers — consistent with the traditional preference for Fu Ling Pi in swelling.

Back to Table of Contents

The Preclinical Diuretic Research

The traditional claim that Poria promotes urination has been tested most directly in rodents. In a 2012 study, rats given a salt-water (saline) load were fed by mouth either an ethanol extract or a water (aqueous) extract of the surface layer of Poria — the outer skin, Fu Ling Pi. The ethanol extract significantly increased urine output and caused a notable rise in sodium excretion, with little or no effect on potassium excretion. The three doses of the water extract produced only a slight increase in urine output, and their rise in sodium and potassium excretion did not reach statistical significance; the authors concluded that the ethanol extract, not the water extract, has the marked diuretic effect. A 2013 follow-up from the same group split the ethanol extract into fractions. The ethyl acetate and n-butanol fractions were the diuretic ones: both raised urine output and sodium and chloride excretion, and the ethyl acetate fraction had no effect on potassium excretion. The authors suggested that this potassium-saving effect may be related to the triterpenoid components, particularly the lanostane tetracyclic triterpenoids — supporting the idea that the lanostane triterpenes are among the active diuretic principles. In plain words: in these rats, the active fractions moved sodium (and water with it) out into the urine while leaving potassium behind.

This is genuinely useful evidence: it shows the traditional observation has a plausible chemical basis, and it points to specific molecules that can be studied further. But two honest caveats apply. First, a diuretic effect in a rat given a concentrated extract does not automatically translate to a meaningful effect in a person eating a normal culinary or decoction dose. Second, many of these studies use doses far higher, relative to body weight, than anyone would consume. Preclinical diuretic activity is a reason for scientific interest — not a demonstration of clinical benefit.

Back to Table of Contents

How Poria May Differ from Conventional Diuretics

One of the more interesting threads in the research is that Poria's diuretic action appears mechanistically different from the common prescription diuretics. Conventional loop and thiazide diuretics work by blocking specific sodium transporters in the kidney tubule, which forces sodium — and therefore water — out in the urine, but often at the cost of dumping potassium as well. That potassium loss is a major reason those drugs require monitoring.

In the rat studies described above, the outer-skin extract and its active fractions increased urine output and sodium excretion without the potassium loss seen with loop and thiazide diuretics. Some accounts of Poria go further and describe certain of its triterpenes as aldosterone antagonists — that is, as substances that may blunt the hormone signal (aldosterone) that tells the kidney to retain sodium and water. If that mechanism holds up, it would make Poria pharmacologically more like a mild potassium-sparing diuretic than like a loop diuretic. This could help explain the traditional description of Poria as "gentle," and it is consistent with the observation that classic formulas did not seem to cause the fatigue and cramping associated with potassium depletion.

The important word remains may. The aldosterone-antagonism idea is a proposal rather than a measured result: no study testing Poria constituents on aldosterone was found, and no controlled human trial has measured electrolytes, so it is a hypothesis rather than an established fact. The rat findings also do not show that Poria is safe to combine with prescription diuretics or potassium-sparing drugs: Poria fractions raised sodium excretion while sparing potassium in rats — the same direction as potassium-sparing drugs — and the combined effect on blood potassium has not been tested in people. For context on the electrolytes involved, see our pages on Potassium and Sodium.

Back to Table of Contents

Poricoic Acids and Kidney-Fibrosis Research

A distinct and more recent research line concerns the poricoic acids — a family of triterpenes named after Poria — and their effects on the diseased kidney. In rodent models of chronic kidney disease (for example, adenine-induced or surgically-induced renal injury), poricoic acid A and related compounds have been reported to reduce markers of renal fibrosis, the scarring process that progressively destroys kidney function. The proposed molecular targets are well-known fibrosis pathways: TGF-β/Smad signaling and Wnt/β-catenin signaling, both of which drive the transformation of kidney cells into scar-producing myofibroblasts.

This body of work — much of it emerging from metabolomics-focused laboratories studying Poria in chronic renal failure models — is scientifically substantial and mechanistically detailed. It is also, without exception, preclinical. There are no adequately powered human trials showing that Poria or purified poricoic acids slow the progression of chronic kidney disease in people. The research is preclinical and has not been tested in people with kidney disease, and people with impaired kidneys handle both fluids and herbal compounds differently and are more vulnerable to harm. See our page on Kidney Disease for the clinical picture.

A 2025 review of Poria and its surface layer brings this work together. It reports that the surface layer showed a stronger diuretic effect than Poria itself (the inner sclerotium), and that the ethanol extract of the surface layer and its components improved acute kidney injury, the transition from acute kidney injury to chronic kidney disease, and chronic kidney disease such as diabetic kidney disease, nephrotic syndrome and tubulointerstitial nephropathy, and protected against renal fibrosis, in experimental (preclinical) studies. The review lists the pathways involved, including TGF-β1/Smad, Wnt/β-catenin, NF-κB and Keap1/Nrf2 signalling and the renin-angiotensin system.

Back to Table of Contents

Traditional Formulas for Fluid Retention

In practice, Poria has almost never been used alone for fluid problems — it is a team player in classic formulas, which is one reason its individual contribution is so hard to isolate. The best-known fluid-related formulas containing Poria include:

Because these formulas contain four or five active herbs, any clinical benefit reported for them cannot be credited to Poria specifically. When you read that "a Poria formula helped with edema," the honest interpretation is that a combination that includes Poria was studied — not Poria in isolation.

Wu Ling San is the same five-herb formula known in Japan as Goreisan, and in Japan it has been studied in people:

As with every formula, these results are for the five-herb mixture, not Poria alone.

Back to Table of Contents

What We Still Don't Know

To keep the picture honest, here is what the current evidence does not establish:

None of this makes Poria worthless — it has a long safety record and a chemistry worth studying. It simply means the strong, specific claims sometimes made for it online run well ahead of the data.

Back to Table of Contents

Practical Use, Forms & Cautions

Forms. Poria is sold as dried sclerotium slices or cubes (for decoctions and soups), as powder, and as concentrated extract capsules or granules. In traditional cooking it is bland and mild, and it is a common ingredient in medicinal congees and soups. A typical decoction dose in TCM references is on the order of 9–15 grams of dried sclerotium, but this is a traditional guideline, not a clinically validated dose.

Cautions:

Back to Table of Contents

Key Research Papers

  1. Zhao YY, Feng YL, Du X, Xi ZH, Cheng XL, Wei F (2012). Diuretic activity of the ethanol and aqueous extracts of the surface layer of Poria cocos in rat. Journal of Ethnopharmacology 144(3):775-8. — PubMed PMID: 23058989
  2. Feng YL, Lei P, Tian T, Yin L, Chen DQ, Chen H, Mei Q, Zhao YY, Lin RC (2013). Diuretic activity of some fractions of the epidermis of Poria cocos. Journal of Ethnopharmacology 150(3):1114-8. — PubMed PMID: 24184192
  3. Wang M, Chen DQ, Chen L, Cao G, Zhao H, Liu D, Vaziri ND, Guo Y, Zhao YY (2018). Novel inhibitors of the cellular renin-angiotensin system components, poricoic acids, target Smad3 phosphorylation and Wnt/β-catenin pathway against renal fibrosis. British Journal of Pharmacology 175(13):2689-2708. — PubMed PMID: 29679507
  4. Zhao YY, Feng YL, Bai X, Tan XJ, Lin RC, Mei Q (2013). Ultra performance liquid chromatography-based metabonomic study of therapeutic effect of the surface layer of Poria cocos on adenine-induced chronic kidney disease provides new insight into anti-fibrosis mechanism. PLoS One 8(3):e59617. — PubMed PMID: 23555727
  5. Guo ZY, Wu X, Zhang SJ, Yang JH, Miao H, Zhao YY (2025). Poria cocos: traditional uses, triterpenoid components and their renoprotective pharmacology. Acta Pharmacologica Sinica 46(4):836-851. — PubMed PMID: 39482471
  6. Ríos JL (2011). Chemical constituents and pharmacological properties of Poria cocos. Planta Medica 77(7):681-91. — PubMed PMID: 21347995
  7. Wu Ling San (Poria-containing formula) and fluid regulation. — PubMed
  8. Esteban CI (2009). Medicinal interest of Poria cocos (= Wolfiporia extensa). Rev Iberoam Micol 26(2):103-7. — PubMed PMID: 19631158
  9. Isogai T, Morita K, Okada A, Michihata N, Matsui H, Miyawaki A, Jo T, Yasunaga H (2025). Association between complementary use of Goreisan (a Japanese herbal Kampo medicine) and heart failure readmission: A nationwide propensity score-matched study. Journal of Cardiology 85(3):220-228. — PubMed PMID: 39341374
  10. Hong S, Shinya Y, Wang Z, Bendok BR, Saito N (2026). Preventive effect of postoperative Goreisan administration on symptomatic recurrence of chronic subdural hematoma: a systematic review and meta-analysis. Neurological Research 48(6):686-698. — PubMed PMID: 40740071

PubMed Topic Searches

  1. PubMed: Poria cocos diuretic
  2. PubMed: Poricoic acid kidney
  3. PubMed: Poria CKD fibrosis
  4. PubMed: Wu Ling San edema

Back to Table of Contents

External Authoritative Resources

Back to Table of Contents

Connections

Back to Table of Contents